Quantcast

Latest Food and Drug Administration Stories

2014-07-17 08:28:41

SANTA ROSA, Calif., July 17, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN) today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014. In June 2014, Ruthigen's Investigational New Drug (IND) application became effective following review by the U.S. Food and Drug Administration (FDA). Ruthigen is developing RUT58-60 as a safe and fast...

2014-07-16 23:10:51

Dr. Ginette Collazo, a 15 year veteran of helping drug, biologic and device firms reduce manufacturing errors by 50 percent or more, will conduct a one-of-a-kind workshop that teaches quality managers and manufacturing excellence professionals how to reduce errors and improve quality metrics. Based on her ground-breaking research, Dr. Collazo explains how small improvements in both manufacturing systems and improved employee training can deliver big results. Falls Church, VA (PRWEB) July...

2014-07-16 23:10:07

On July 11, the FDA informed consumers on the recall of all White & Blue Lion Inc. Tattoo Ink, Needles and Kits due to microbial contamination. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 16, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Tattoo Ink, Needles and Kits. The FDA informed...

2014-07-16 23:04:33

A Food and Drug Administration advisory panel recently met to assess the safety of a device used during hysterectomies and other uterine surgeries. In the wake of that meeting, the defective medical device lawyers of Levy Baldante encourage the FDA to take steps to protect citizens. Philadelphia, PA (PRWEB) July 16, 2014 The law firm of Levy, Baldante, Finney, Rubenstein, Cohen & Chizmar, P.C. recognizes the deep-seated concerns shared by many in regard to laparoscopic power...

2014-07-16 20:23:36

Animal Deaths Emerging Nationwide due to Illegal Compounded Drugs WASHINGTON, July 16, 2014 /PRNewswire-USNewswire/ -- Today, the Animal Health Institute, along with the experts in the field of animal health and veterinary medicine brought together consumers, media, veterinary experts, policymakers and industry stakeholders for a teleconference and two Congressional briefings calling for greater action by the U.S. Food and Drug Administration (FDA) on illegal animal drug...

2014-07-16 16:23:50

WINNETKA, Calif., July 16, 2014 /PRNewswire/ -- Green Cures & Botanical Distribution Inc (OTC Pink: GRCU) ("Green Cures") provided the following updates. CBD Capsules First, Green Cures management announced that due to higher than expected demand for the company's CBD Capsules, Green Cures is presently experiencing a shortage of inventory of these capsules. Customers who had open orders for the CBD Capsules as of July 15, 2014, are currently being notified that the company is...

2014-07-16 12:27:49

BETHESDA, Md., July 16, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) has confirmed FDA's Stephen Ostroff, M.D., Acting Chief Scientist in the Office of the Commissioner will present "FDA's Views on Scientific Advances and their Impact on Manufacturing of the Future" on September 8, 2014 in at the opening plenary session of the 2014 PDA/FDA Joint Regulatory Conference in Washington, DC at the Renaissance Hotel. The Conference dates are September 8-10, 2014,...

2014-07-16 08:29:39

CASTLE ROCK, Colo., July 16, 2014 /PRNewswire/-- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and young adult patients that are at low risk for appendicitis, updated on recent activities concerning its U. S. Food and Drug Administration (FDA) submission for the APPY1 Test that was filed in March 2014. The...

2014-07-16 08:29:36

FREDERICK, Md., July 16, 2014 /PRNewswire/ -- ImQuest Pharmaceuticals was recently notified by the US Food and Drug Administration of the approval of its Investigational New Drug (IND) application to study the safety in Phase 1 clinical trials of its vaginal gel containing the nonnucleoside reverse transcriptase HIV Inhibitor IQP-0528. Preclinical studies have shown that IQP-0528 is highly effective against virus strains found throughout the world, prevents HIV transmission in...

2014-07-15 23:11:01

On July 11, the FDA alerted healthcare professionals not to use drugs marketed as sterile produced by Unique Pharmaceuticals Ltd. as they may be contaminated. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 15, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Sterile Drug Products. The FDA notified...


Latest Food and Drug Administration Reference Libraries

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Chilean Sea Bass, Dissostichus eleginoides
2013-01-12 08:49:28

The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...

More Articles (2 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related